|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,417.00 JPY | -0.92% |
|
+0.83% | +11.25% |
| Market Cap | 1,146B 7B 6.16B 5.73B 5.26B 9.88B 672B 10.01B 68.13B 26.61B 332B 26.29B 25.73B | P/E 2027 * |
16.2x | P/E 2028 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 947B 5.79B 5.09B 4.74B 4.35B 8.17B 555B 8.27B 56.29B 21.98B 274B 21.72B 21.26B | EV / Sales 2027 * |
2.08x | EV / Sales 2028 * | 2.09x |
| Free-Float |
80.98% | Yield 2027 * |
3.21% | Yield 2028 * | 3.18% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | -0.92% | ||
| 1 week | +0.83% | ||
| Current month | +1.21% | ||
| 1 month | +0.29% | ||
| 3 months | +4.52% | ||
| 6 months | +6.66% | ||
| Current year | +11.25% |
| 1 week | 2,378 |  | 2,457 |
| 1 month | 2,336 | | 2,507 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,596 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 76 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.92% | +0.83% | +46.04% | -7.27% | 7B | |
| +0.53% | +1.11% | +16.54% | +74.23% | 49.38B | |
| +0.53% | +2.75% | +62.41% | +111.34% | 36.35B | |
| +2.31% | +0.47% | -8.44% | +22.20% | 11.87B | |
| -0.85% | -4.02% | +11.94% | +71.29% | 11.53B | |
| +0.09% | 0.00% | +37.53% | +136.73% | 8.99B | |
| +1.19% | +0.85% | +13.68% | +35.54% | 6.76B | |
| -0.53% | -2.62% | +1.82% | +173.35% | 6.46B | |
| +3.51% | -10.69% | -31.55% | +1.09% | 5.49B | |
| -1.30% | -6.70% | +20.55% | +106.45% | 4.41B | |
| Average | +0.19% | -1.19% | +17.05% | +72.50% | 14.82B | |
| Weighted average by Cap. | +0.34% | +0.21% | +25.66% | +79.68% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 454B 2.78B 2.44B 2.27B 2.09B 3.92B 266B 3.97B 27B 10.55B 131B 10.42B 10.2B | 444B 2.72B 2.39B 2.22B 2.04B 3.83B 260B 3.88B 26.42B 10.32B 129B 10.19B 9.97B |
| Net income | 70.98B 434M 381M 355M 326M 612M 41.59B 620M 4.22B 1.65B 20.54B 1.63B 1.59B | 62.51B 382M 336M 313M 287M 539M 36.63B 546M 3.72B 1.45B 18.09B 1.43B 1.4B |
| Net Debt | -199B -1.22B -1.07B -996M -915M -1.72B -117B -1.74B -11.84B -4.62B -57.63B -4.57B -4.47B | -218B -1.33B -1.17B -1.09B -1B -1.88B -128B -1.91B -12.97B -5.07B -63.14B -5.01B -4.9B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-28 | JP¥2,417.00 | -0.92% | 1,462,400 |
| 26-07-27 | JP¥2,439.50 | +0.18% | 1,568,600 |
| 26-07-24 | JP¥2,435.00 | +1.52% | 1,507,300 |
| 26-07-23 | JP¥2,398.50 | -0.27% | 1,081,400 |
| 26-07-22 | JP¥2,405.00 | +0.33% | 1,236,400 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
